Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Caelyx pegylated liposomal“
Suchtreffer
Begriffe & Kennungen
Caelyx pegylated liposomal
Eintrag öffnenCaelyx pegylated liposomal · 4.1 Therapeutic indications · 1
Eintrag öffnenCaelyx pegylated liposomal · 4.3 Contraindications · 1
Eintrag öffnenCaelyx pegylated liposomal · 4.3 · Caelyx pegylated liposomal must not be used to treat AIDS-KS that may be treated effectively with local therap
Eintrag öffnenCaelyx pegylated liposomal · 4.3 · Hypersensitivity to the active substance, peanut or soya, or to any of the excipients listed in section 6.1.
Eintrag öffnenCaelyx pegylated liposomal · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenCaelyx pegylated liposomal · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenCaelyx pegylated liposomal · 4.5 · No formal medicinal product interaction studies have been performed with Caelyx pegylated liposomal, although
Eintrag öffnenCaelyx pegylated liposomal · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenCaelyx pegylated liposomal · 4.8 Undesirable effects · 1
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · 10 Legionella, Microsporidium, Salmonella, Staphylococcus, Toxoplasma, Tuberculosis)a Neoplasms benign, Not kn
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · 11 Cardiotoxicity Rare Ventricular arrhythmia Bundle branch block right Conduction disorder Atrioventricular b
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · 12 Hyperhidrosis Skin hyperpigmentation Uncommon Dermatitis Dermatitis exfoliative Acne Skin ulcer Dermatitis
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · 13 Blood creatinine increased Injury, poisoning and Uncommon Radiation recall phenomenona procedural complicat
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · 14 increased risk of cardiovascular toxicity with conventional doxorubicin. Only 13 of these 88 patients (15%)
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · Cardiac toxicity An increased incidence of congestive heart failure is associated with doxorubicin therapy at
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · Description of selected adverse reactions Palmar plantar erythrodysaesthesia The most common undesirable effec
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · In addition, endomyocardial biopsies were performed in 8 solid tumour patients with cumulative anthracycline d
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · In patients with solid tumours, including a subset of patients with breast and ovarian cancers, treated at a d
Eintrag öffnenCaelyx pegylated liposomal · 4.8 · In the pivotal phase III trial versus doxorubicin, 58/509 (11.4%) randomised subjects (10 treated with Caelyx
Eintrag öffnen